Clinical Evaluation of MDT-2111 in Subjects With Small Aortic Annuli and Symptomatic Severe Aortic Stenosis

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

September 30, 2019

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

MDT-2111 TAVI 23 mm

Device: 23 mm MDT-2111 System for Transcatheter Aortic Valve Implantation (TAVI) Transcatheter Aortic Valve Implantation (TAVI) using the 23 mm MDT-2111 system.

Trial Locations (4)

Unknown

Shonan Kamakura General Hospital, Kamakura

National Cerebral and Cardiovascular Center, Suita

Osaka University Hospital, Suita

Saitama Medical University, Hidaka

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY